495
Views
6
CrossRef citations to date
0
Altmetric
Research Article

An optimized protocol for the in vitro generation and functional analysis of human PD1/PD-L1 signal

, , &
Pages 31-36 | Received 09 Sep 2017, Accepted 16 Nov 2017, Published online: 18 Dec 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Fang Bao, Hai-Ying Bai, Zheng-Rong Wu & Zhi-Gang Yang. (2021) Phenolic compounds from cultivated Glycyrrhiza uralensis and their PD-1/PD-L1 inhibitory activities. Natural Product Research 35:4, pages 562-569.
Read now
Mostafa Khedri, Khalil Abnous, Houshang Rafatpanah, Maryam Sadat Nabavinia, Seyed Mohammad Taghdisi & Mohammad Ramezani. (2020) Development and Evaluation of Novel Aptamers Specific for Human PD1 Using Hybrid Systematic Evolution of Ligands by Exponential Enrichment Approach. Immunological Investigations 49:5, pages 535-554.
Read now

Articles from other publishers (4)

Melissa Biemond, David Vremec, Daniel HD Gray, Philip D Hodgkin & Susanne Heinzel. (2023) Programmed death receptor 1 (PD‐1) ligand Fc fusion proteins reduce T‐cell proliferation in vitro independently of PD‐1 . Immunology & Cell Biology.
Crossref
Júlia Anna Láng, Zsófia Cselovszkiné Balogh, Mónika Fizilné Nyitrai, Cintia Juhász, Anna Katalin Baráné Gilicze, Attila Iliás, Zsolt Zólyomi, Csaba Bodor & Erzsébet Rábai. (2020) In vitro functional characterization of biosimilar therapeutic antibodies. Drug Discovery Today: Technologies 37, pages 41-50.
Crossref
Xinjian Xu, Ji Lv, Fang Guo, Jing Li, Yitao Jia, Da Jiang, Na Wang, Chao Zhang, Lingyu Kong, Yabin Liu, Yanni Zhang, Jian Lv & Zhongxin Li. (2020) Gut Microbiome Influences the Efficacy of PD-1 Antibody Immunotherapy on MSS-Type Colorectal Cancer via Metabolic Pathway. Frontiers in Microbiology 11.
Crossref
Ming-Zhen Zhao, Yu Sun, Xiao-Feng Jiang, Li Liu, Li Liu & Li-Xin Sun. (2020) Promotion on NLRC5 upregulating MHC-I expression by IFN-γ in MHC-I–deficient breast cancer cells. Immunologic Research 67:6, pages 497-504.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.